AMRN - Amneal Pharma in pact with Strides to launch generic Vascepa
2023-12-01 13:40:47 ET
More on Amarin, Amneal, etc.
- Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript
- Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.06, revenue of $620M beats by $15.47M
- Amarin GAAP EPS of -$0.05, revenue of $66M
For further details see:
Amneal Pharma in pact with Strides to launch generic Vascepa